Australia: Shares end higher on US Fed survey, stimulus hopes
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SYDNEY] Australian shares ended higher for a second straight session on Thursday, with financials leading gains, as an upbeat US Fed survey and hopes of more stimulus boosted risk appetite.
A US Federal Reserve survey showed US business activity and employment increased modestly through late-August, though the sluggish and uneven growth spurred expectations for Washington to reach a deal on fresh stimulus.
"It's a one-way train at the moment for equities, and you've got to trade what you see while we're in a low-interest rate environment," said Nick Twidale, director at Xchainge.
"I think the pattern's set for the next few weeks but I think we might see some sharp corrections as well." The S&P/ASX 200 index finished 0.8 per cent higher to close at 6,111.60, its highest in over a week.
But gains were somewhat capped as Covid-19 hot spot Victoria reported a triple-digit rise in daily cases for the first time in four days, blunting hopes for a speedy rollback of lockdowns.
Heavyweight financials finished 1.3 per cent higher, supported by a strong showing from top lenders Westpac Banking Corp and Commonwealth Bank of Australia which rose 1.6 per cent and 0.8 per cent, respectively.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
New Zealand's benchmark S&P/NZX 50 index rose 1.3 per cent, its most in nearly two weeks, to end at 12,055.05.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant